We describe bias resulting from individualized treatment selection, which occurs when treatment has heterogeneous effects and individuals selectively choose treatments of greatest benefit to themselves. this pernicious bias may confound estimates from observational studies and lead to important misinterpretation of intent-to-treat analyses of randomized trials. Despite the potentially serious threat to inferences, individualized treatment selection has rarely been formally described or assessed. Methods: the Moving to Opportunity trial randomly assigned subsidized rental vouchers to low-income families in high-poverty public housing. We assessed the Kessler-6 psychological distress and Behavior Problems index outcomes for 2,829 adolescents 4-7 years after randomization. among families randomly assigned to receive vouchers, we estimated probability of moving (treatment), predicted by prerandomization characteristics (c statistic = 0.63). We categorized families into tertiles of this estimated probability of moving, and compared instrumental variable effect estimates for moving on behavior problems index and Kessler-6 across tertiles. Results: instrumental variable estimated effects of moving on behavioral problems index were most adverse for boys least likely to move (b = 0.93; 95% confidence interval: 0.33, 1.53) compared with boys most likely to move (b = 0.14; 95% confidence interval: −0.15, 0.44; P = 0.02 for treatment × tertile interaction). effects on Kessler-6 were more beneficial for girls least likely to move compared with girls most likely to move (−0.62 vs. 0.02; interaction; P = 0.03). Conclusions: evidence of individualized treatment selection differed by child gender and outcome and should be evaluated in randomized trial reports, especially when heterogeneous treatment effects are likely and nonadherence is common. (Epidemiology 2016;27: 265-275) 
S
ocial and pharmacologic treatments may benefit some people but harm others. [1] [2] [3] [4] [5] the Moving to Opportunity (MtO) trial, which randomly assigned volunteer low-income families to receive subsidized rental vouchers to move out of public housing, demonstrated qualitative effect modification by child gender and family vulnerabilities. 1, 6 as in most trials, adherence to random assignment was imperfect. Parents, predominantly single mothers, decided whether to move to private market apartments or to remain in their public housing apartments. the expected impact of moving on children presumably influenced mothers' decisions, but it is unknown whether families whose children were most likely to benefit were in fact most likely to move. We call such a process, in which treatment received is associated either positively or negatively with the effects of that treatment, individualized treatment selection. in observational studies, individualized treatment selection is a pernicious type of confounding that arises when a treatment effect modifier also influences treatment received. When an instrumental variable is available, for example from a randomized controlled trial (rct), individualized treatment selection can be assessed and possible effect heterogeneity can be formally evaluated. Such effect heterogeneity is usually of great substantive interest, because it implies that the optimal treatment differs between individuals. rcts are often intended to support "scaling up" or universalizing a treatment or policy. if individualized treatment selection occurs, the intention to treat effect estimate can severely misrepresent the effects of such untargeted implementation.
We aim in this article to formally describe individualized treatment selection and illustrate an approach, related to the Peck et al. 7, 8 study using propensity score estimates from prerandomization characteristics, to evaluate individualized treatment selection in MtO. We first contrast individualized treatment selection with conventional confounding, showing why it can lead to false conclusions about population average treatment effects in observational studies or rcts. We emphasize that randomization does not solve this problem, because even when the population average treatment effect is null, the sharp null (no effect for anyone in the sample) may not hold. 9 We hypothesized that families with children most likely to benefit from moving out of high-poverty public housing were also those most likely to do so.
CONVENTIONAL CONFOUNDING COMPARED WITH INDIVIDUALIZED TREATMENT SELECTION
the assumption of "no unmeasured confounding" generally requires that counterfactual outcomes under any particular treatment regime are independent of which treatment is actually received. conventionally, confounding occurs because individuals who would have better outcomes under any treatment regime selectively receive one particular treatment. For example, if children with underlying health advantages are more likely to move to high-socioeconomic status (SeS) neighborhoods (vs. lower-SeS neighborhoods) than children with health vulnerabilities, the comparison of outcomes for children in high-SeS versus low-SeS communities will not correspond with the effect of neighborhood SeS on health.
We consider a more subtle type of confounding, where treatments have different effects for different people (individual effect heterogeneity), and individuals selectively choose the treatment they anticipate as most beneficial to them personally. For example, some children might have better health responses to high-SeS than low-SeS neighborhoods, while the health of other children would be best-served by living in low-SeS neighborhoods (e.g., with less racial harassment and more supportive social networks). if families who would thrive in high-SeS neighborhoods selectively move to such communities, while families who would thrive in low-SeS areas selectively move to low-SeS communities, the contrast in outcomes between children residing in high-and low-SeS communities is not necessarily the average causal effect of neighborhood type for all, or any subgroup of, children. this is "confounding by potential effect size," conceptualizing effect size as an unobserved variable defined for each person before exposure. We define each person's potential effect size as the difference between that individual's counterfactual outcomes under alternative treatments (similar contrasts define "causal response types" 10 ). individualized treatment selection is only possible if treatment effects differ between people, thus our discussion relates closely to research on heterogeneous treatment effects. 11, 12 although health research rarely quantifies this type of confounding formally in rcts, individualized treatment selection seems plausible for many behavioral or lifestyle exposures. individuals know whether they are receiving treatment and may have insight into the contexts most beneficial for them personally (or for their children). For example, when choosing a school or residential neighborhood, parents probably carefully consider where their children are most likely to flourish. individualized treatment selection may have received so little attention because empirical evaluation of this phenomenon is difficult. Observational studies without instrumental variables cannot distinguish individualized treatment selection from conventional confounding. However, with randomization or another convincing instrumental variable, it may be possible to detect it by identifying subgroups likely to take up the treatment and, within such subgroups, estimating treatment effects. a typical definition of confounding is that the probability an individual will receive a particular treatment is associated with that individual's counterfactual outcome under some treatment:
COUNTERFACTUAL DEFINITIONS
confounding occurs, for example, if some cause of X, say W, also influences either Y x=1 or Y x=0 or both (Figure 1 ). individualized treatment selection occurs when the probability an individual will receive a particular treatment is associated with the individual's treatment response. Define each individual's treatment response β i as the contrast between that person's counterfactual outcome under treatment (Y x=1,i ) versus no treatment (Y x=0,i ):
Positive β i thus indicates treatment harms person i, while negative values indicate treatment is beneficial.
individualized treatment selection implies:
For example, if treatment selection is advantageous, the probability of treatment uptake is lower among those who would be harmed by treatment than among those who would benefit from treatment:
alternatively expressed we would expect
returning to the causal diagram, if the effect of W on Y x=1 differs from the effect of W on Y x=0 , then W modifies the potential treatment effect and, because W also influences X, this induces individualized treatment selection (Figure 2) . in other words, if an unobserved factor both influences treatment and modifies the effects of treatment, this implies individualized treatment selection.
if individualized treatment selection is induced by an unobserved factor, the estimate of β from analyses based on measured confounders in an observational study will equal neither the population average treatment effect (see Box 1 for a definition of this and other estimands discussed here), nor any subgroup effect.
Situation 1: Observational Study
consider a hypothetical situation illustrating the bias in estimating the average causal effect in an observational study (see eappendix 1 for a corresponding simulation in Stata; http://links.lww.com/eDe/a1000). Define W as an unobserved treatment effect modifier (and also a confounder), that for simplicity affects Y x=1 but not Y x=0 (Figure 2 ). We will say
thus, treatment harms individuals with W = 1 (β = 1), and benefits individuals with W = 0 (β = −1). Suppose half the population has W = 1, leading to a population average treatment effect of zero, but people with W = 1 are less likely to take treatment X than people with W = 0: So far this seems like typical confounding. We cannot identify the effect of X on Y because an unmeasured factor influences both X and the counterfactual outcomes of Y. [13] [14] [15] analyses stratified by W will provide correct effect estimates for each group (1 or −1) and averaging or inverse probability weighting based on the prevalence of W will provide the correct population average treatment effect (shown in simulation 1). individualized treatment selection diverges from typical confounding however, because if W is unmeasured, even an intention-to-treat estimate from an rct may be non-null when the true population average treatment effect is null.
Situation 2: Randomized Trial with Imperfect Compliance Only in the Treatment Arm
let Z represent random assignment of treatment X. assume X is not offered to those in Z = 0 and X is offered to those in Z = 1. although X is offered to individuals randomly assigned to Z = 1, not all of those offered X take up the treatment (as illustrated by incomplete treatment adherence in most rcts). Suppose that when offered X, take-up varies by the unmeasured characteristic W, as above:
eappendix 3 provides Stata code simulating data following the rules above (http://links.lww.com/eDe/a1000). the counterfactuals are as defined above, so the population FIGURE 2. Directed acyclic graph (DAG) illustrating individualized treatment selection. Individualized treatment selection occurs because an unmeasured trait W that affects X influences different counterfactual outcomes of Y to different extents. For clarity in a DAG, in this example, we show that W influences both X and one of the counterfactual outcomes of Y (if X is set to 1), but has no effect on the other counterfactual outcome of Y (if X is set to 0). Because W has a different effect on each of the two counterfactual outcomes, it also influences β, the effect size of treatment, which is fully determined by the contrast of the two counterfactual values of Y. Under this diagram, the treatment received (X) will be associated with the response to that treatment (β) and individualized treatment selection is expected.
average treatment effect of X is zero. the intentional-to-treat effect estimate would be −0.1 (eappendix 2; http://links. lww.com/eDe/a1000). thus, although the population average treatment effect is zero, the intention-to-treat estimate is nonzero. adjusting the intention-to-treat estimate for nonadherence to generate the instrumental variable estimate does not recover the population average treatment effect but rather gives the effect of treatment on the treated
. .
note this is equivalent to the effect of treatment on the treated only because nobody in the Z = 0 group could access X and in our hypothetical scenario, W has no effect on Y x=1 . in other situations with individualized treatment selection, the instrumental variable estimate does not equal the effect of treatment on the treated or the observational effect. although stratifying on W produces correct β estimates for the effect of X in each stratum, simply adjusting the intention-to-treat regression (i.e., the effect of Z on Y) for W does not change the intention-to-treat estimate from the (non-null) unadjusted intention-to-treat effect.
thus, even in a situation where the population average treatment effect is null, the intention-to-treat effect estimate may not be null. it is often assumed that in a well conducted and properly analyzed rct, the intention-to-treat estimate is guaranteed to be null if the average effect of receiving treatment on the outcome is null. However, this guarantee only holds under the sharp null, i.e., the effect of receiving treatment on the outcome is null for every individual in the population, or if adherence to assigned treatment is perfect. 9 Under individualized treatment selection, even if the population average treatment effect is null, the intention-to-treat need not be centered on the null. Similarly, it is often assumed that nonadherence in a trial results in an intention-to-treat effect estimate closer to the null than the effect of receiving treatment. in the context of individualized treatment selection, this is not necessarily the case (eFigure; http://links.lww.com/eDe/a1000).
We now turn to an empirical example to assess individualized treatment selection, by comparing effect estimates across probability of taking the treatment in the MtO trial. We selected adolescent mental health as an outcome a priori because MtO has heterogeneous effects on children's mental health for children with different prerandomization characteristics, 1, 6, 16 and children's mental health and behavioral problems seem especially salient to mothers' move decisions. [17] [18] [19] 
METHODS

Data
MtO was an rct in which volunteer families with children were recruited from public housing developments in high-poverty neighborhoods and randomly assigned to a control arm or one of two treatment arms.
1,20-23 the control group received no further subsidy but could remain in public housing. the "regular section 8" treatment arm received subsidies to rent private market apartments. the "low-poverty neighborhood section 8" also received rental subsidies, but only if they moved to low-poverty neighborhoods (<10% of the census tract living in poverty; participants received housing counseling to help find apartments). We pool the regular section 8 and low-poverty section 8 groups, given previous evidence of similar mental health effects.
1,16 as a result, the treatment received includes moves from public housing into private market apartments, and moves from very high poverty to a range of lower poverty neighborhoods. Survey data were collected at baseline and interim follow-up (4-7 years after baseline). We use outcomes from MtO tier 1 restricted access Data on 2,829 adolescents randomly assigned from 1994 to 1997 who answered interim surveys in 2002. 20, 21, 23 northeastern University's institutional review Board approved this study.
Outcome Measures
in 2002, past-month psychological distress was measured by Kessler's K-6 scale, 24 which includes five-option likert scales ("none of the time" to "all of the time") for six items (so depressed nothing could cheer you up; nervous; restless or fidgety; hopeless; everything an effort; worthless). Past 6-month externalizing behaviors were assessed with 11 items from the Behavior Problems index, 25 such as "i lie or cheat" and "i have a hot temper," ranked from 0 (not true) to 2 (often true). Behavior Problems index and Kessler-6 scores were estimated with two-parameter binary item response theory models and standardized. 24 For both outcomes, higher scores indicate worse outcomes.
Treatment Take-up/Move treatment take-up, corresponding to the treatment variable X in the individualized treatment selection explanation, consisted of using section 8 vouchers offered to the experimental groups to move. all control families were therefore untreated.
Predictors of Take-up
We modeled take-up (among the treatment group only) as a function of all available prerandomization (baseline) variables, listed in table 1 and in Figures 3 and 4 notes.
Analysis
We estimated intention-to-treat effects with linear regression models of randomized assignment predicting mental health. We used random assignment as an instrumental variable in two-stage least squares models to estimate the effect of take-up on mental health, with adjustment for baseline covariates.
11 Sensitivity analyses adjusted only for sex and site produced results similar to covariate adjusted models (etable; http://links.lww.com/eDe/a1000). We then tailored these intention-to-treat and instrumental variable analyses to test for individualized treatment selection. among families randomly assigned to receive rental vouchers, we use logistic regression to model the probability of take-up as a function of the prerandomization (baseline) family and child characteristics. We then used this model to predict the probability that each family, treatment, or control would have taken up the voucher if randomized to receive one. For control group families, this was an out-of-sample prediction. this model is not causal: many variables we use to predict take-up may simply proxy for unmeasured determinants of moving. Our goal was to predict take-up; we can assess the occurrence of individualized treatment selection even if the model is misspecified for causal determinants, provided the model predicts take-up. Estimates were derived using instrumental variables analysis with two-stage least square regression. Regression model controls for age, sex, race/ethnicity, parental education, family structure, parent's marital status, parent's employment status, parent's receipt of Aid to Families with Dependent Children/Temporary Assistance for Needy Families (AFDC/TANF); parent's teen parent status; no teens in household; sibling combination, household size, presence of family health vulnerability/disability, family disability, family experience of victimization, neighborhood/ mobility variables (Table 1) , and the following interaction terms (treatment × tertile of take-up, treatment × gender, tertile of take-up × gender, and treatment × gender × tertile of take-up). Gender-specific estimates are calculated using postestimation commands; estimates are weighted and account for clustering at family level. Instrumental variable estimates for boys' behavior problems index in families least and most likely to take the treatment were 0.93 versus 0.14, respectively (P = 0.02 for test of interaction). Unexpectedly, instrumental variable estimates for Kessler-6 suggest that girls in families least likely to move had the greatest benefit compared with girls in families most likely to move (b = −0.62 vs. 0.02; P = 0.03 for test of interaction).
We next categorized families in both treatment and control groups into tertiles of probability of take-up (low, moderate, or high). these categories do not reflect actual move status, but rather the probability of moving if, possibly counter to fact, the family was offered a voucher (the variable W above). We then calculate the intention-to-treat and instrumental variable effect estimates within each tertile of probability of takeup, derived from interaction models. to provide evidence of individualized treatment selection, we test whether estimated health effects of treatment were better for children whose families were most likely to move (illustrated by tertile × treatment arm interactions). this assumes that random assignment is a valid instrumental variable for the effect of take-up. 8 tertile of take-up was coded using two indicator variables instead of a linear term to allow for greater flexibility of treatment effect estimates. given documented treatment effect heterogeneity by gender, 1, 16, 21 final models included three-way interactions between take-up tertile, treatment group, and gender.
intention-to-treat estimates can be interpreted as the mental health effects of offering treatment (regardless of takeup). Since, by design, no controls could access treatment, instrumental variable effect estimates can be interpreted as the effect of treatment among compliers and as the effect of treatment on the treated. 11 if treatment effects were identical for all individuals (i.e., if effects among compliers and noncompliers were equal, implying no individualized treatment selection), the instrumental variable estimate would represent the population average treatment effect. if individualized treatment selection occurs, these effects likely differ. to test this, we estimate the population average treatment effect, using a weighted instrumental variable in which the weights are equal to the inverse of the probability of take-up. We thus also evaluate individualized treatment selection by comparing inverse probability weighted and unweighted instrumental variable models.
all analyses incorporated sampling weights and accounted for family-level clustering of children. We used M-Plus 6.11 (Muthén & Muthén, los angeles, ca) for item response theory analyses and Stata 11.0 (Statacorp lP, college Station, tX) for all other analyses.
RESULTS
the treatment take-up model, based on prerandomization covariates, strongly predicted take-up (positive predictive value = 65%, negative predictive value = 62%, c statistic = 0.63). take-up was more common among younger parents who were currently in school or on aid to Families with Dependent children (aFDc)/welfare (table 1) and in smaller households, but did not differ by child gender. Dissatisfaction with neighborhood, confidence in ability to find a new apartment, and history of applying for section 8 also predicted higher likelihood of moving. take-up differed substantially across sites.
Using predicted probability of take-up from this model, we categorized everyone, including control group families, into three strata: low likelihood of take-up (predicted probability <0.45), moderate likelihood of take-up (probability 0.45-0.61), and high likelihood of take-up (probability >0.61). Some covariates strongly predicted take-up (table 2) . For example, families with health and developmental vulnerabilities at baseline were disproportionately present in the lowest versus highest tertile of takeup probability.
the overall effect of the MtO intervention on adolescent boys' mental health was adverse. 1, 16 Our intention-totreat effect estimates show a graded pattern such that among boys in families least likely to take-up the intervention, the effect of randomization was most harmful, as hypothesized. the intention-to-treat effect estimate on Behavior Problems index for boys in the lowest probability of take-up group was 0.31 (95% confidence interval: 0.12, 0.50), compared with only 0.09 (−0.12, 0.31) among boys in the group with the highest probability of take-up (table 3) . Many families in MtO did not adhere to the assigned treatment, so the intention-to-treat estimate would not necessarily correspond to the effect of receiving treatment. For this reason, estimates adjusted for adherence (instrumental variable estimates) are more relevant. as expected, patterns in evidence of individualized treatment selection observed with intention-to-treat analyses are reflected even more clearly in instrumental variable estimates: the instrumental variable estimate for boys' Behavior Problems index in families least likely to take the treatment was 0.93 (0.33, 1.53), compared with an instrumental variable estimate of only 0.14 (−0.15, 0.44) for boys' Behavior Problems index in families most likely to take up the treatment (P = 0.02 for the test of tertile × treatment; Figure 3, table 3 ). among boys, patterns for Kessler-6 were similar to Behavior Problems index, albeit smaller in magnitude. Boys in the lowest tertile of take-up probability had the highest instrumental variable estimate for the effect of moving on Kessler-6 (b = 0.60; 0.03, 1.17) compared with boys in the highest tertile of take-up probability (b = 0.16; −0.16, 0.47). there was an inverse gradient of treatment effects on Kessler-6 across tertile for boys, with wide cis and a nonsignificant test of tertile × treatment interaction (P = 0.18).
there was no evidence of individualized treatment selection for girls' Behavior Problems index, however there was for girls' Kessler-6. Unexpectedly, instrumental variable estimates for suggest that girls in families least likely to move experienced greater mental health benefits compared to girls in families most likely to move (b = −0.62 [−1.09, −0.14] vs. 0.02 [−0.28, 0.32]; interaction term P value = 0.03; Figure 3) .
Our final analyses demonstrate the implications of individualized treatment selection by comparing (1) instrumental variable estimates of the effect of take-up on mental health, without accounting for individualized treatment selection, and (2) these same instrumental variable analyses, but applying inverse probability weights for treatment (take-up) to account for individualized treatment selection and estimate the population average treatment effect. estimates of the population average treatment effect (based on inverse probability weighting) were farther from the null for boys for Behavior Problems index (Figure 4 ). Without inverse probability weighting, the instrumental variable effect estimate of moving on Behavior Problems index was 0.39 (0.15, 0.64), but this increased 26% after accounting for treatment selection with inverse probability weighting (instrumental variable b = 0.49; [0.20, 0.79)]. therefore, if the boys least likely to move were forced to move, the adverse effects would have been even larger. Similarly, accounting for individualized treatment selection increased the estimated population benefit for K6 associated with treating all girls by 36%.
DISCUSSION
We find mixed support for the hypothesis of individualized treatment selection in the MtO trial. While individualized treatment selection occurred for both boys' and girls' mental health outcomes, the results were in different directions. Findings for boys were consistent with our hypothesis: adverse treatment effects on Behavior Problems index were concentrated among families least likely to move, suggesting that mothers may have correctly anticipated potential harm to their sons when deciding not to move. However, for girls, the opposite pattern emerged: beneficial effects were largest among those least likely to move. gender of the child, a proven treatment effect modifier in MtO, did not itself predict take-up.
the qualitatively different individualized treatment selection for male and female children was unexpected. Our findings may of course be attributable to chance. We also speculate on three possible substantive explanations. Parents may be less able to assess daughters' mental health. 26 Boys are more likely to engage in visible externalizing behaviors, whereas girls more commonly internalize distress. 27 alternatively, parents may prioritize the specific outcomes in our study more for sons than daughters. 28 Parents may even prioritize outcomes for their sons over their daughters, given the particular vulnerabilities facing adolescent boys. 29, 30 Finally, the results may reflect the limitations of our method of evaluating individualized treatment selection, which Baltimore  5%  4%  12%  14%  27%  27%  Boston  35%  31%  22%  25%  11%  12%  los angeles  2%  1%  9%  9%  37%  37%  new York  32%  36%  31%  28%  13%  13%  chicago  26%  28%  25%  25%  12%  11% estimates are weighted for varying treatment assignment ratios across time. Percentages reported are column percentages. analyses include both treatment and control group families (n = 4,248 families).
geD indicates general educational development. assumes that random assignment is a valid instrumental variable for treatment. relaxing this assumption makes individualized treatment selection unidentifiable, but the assumption cannot be proven; the plausibility must be considered on a case by case basis. if randomization influences outcomes via other mechanisms, such as perceptions of empowerment or discrimination through receipt or use of the voucher, such pathways could induce the apparent differences in effects between those who are likely versus unlikely to take up the voucher. individualized treatment selection is a potentially serious problem in observational research and randomized trials, but has received remarkably little attention. Prior analyses using methods similar to ours assumed that individualized treatment selection never occurs. 8, 10 in observational data, it is impossible to distinguish between typical confounding (individuals who would have advantageous outcomes regardless of treatment are more likely to be treated) and individualized treatment selection (individuals select treatments of greatest personal benefit). We leveraged MtO's randomization to evaluate individualized treatment selection, yet our approach recovers the population average treatment effect only if there are no unobserved sources of individualized treatment selection. this cannot be proven in real data. Our analyses focused on risk difference effect estimates because we describe individual-level effects which are easily defined on a linear scale. individualized treatment selection for nonlinear models is an important topic for future research.
individualized treatment selection may arise in "patient preference" trials, which include patient-elected treatment arms alongside randomized treatment assignment, 31, 32 and behavioral trials, where treatment assignment cannot be masked. Blinding is no guarantee against individualized treatment selection if some treatment side effects cause non-adherence and correlate with the treatment's efficacy. [33] [34] [35] although we hypothesized beneficial individualized treatment selection, it is plausible that it is adverse in some situations, when people do not know or act in their own best interest. Health inequalities researchers implicitly invoke adverse individualized treatment selection when speculating that untargeted resources exacerbate inequalities because the most disadvantaged individuals (who would benefit most) are least capable of utilizing the resource. 36 evaluating potential individualized treatment selection is important for assessing observational studies and understanding divergence with randomized trials. individualized treatment selection has immediate clinical and policy relevance: if individuals naturally choose exposures that are in their own best interest, paternalistic policies that force other options may be harmful. MtO families faced substantial social and financial challenges when moving to low poverty neighborhoods. 21 nearly half of MtO families offered vouchers did not move, and many who did move subsequently returned to high-poverty neighborhoods. 37 Families may have chosen in their own best interest, albeit within constrained housing options. in conclusion, we find mixed support for the hypothesis that families who did not take up MtO vouchers acted on accurate predictions that moving would not be in their children's best interest. although probability of take-up was associated with estimated treatment effects, patterns differed by child gender. to our knowledge, this is the first empirical assessment of the magnitude of individualized treatment selection. it remains to be seen whether individualized treatment selection is common, but the possibility merits systematic assessment.
